- Prevention and treatment of malaria, especially Plasmodium falciparum.
- Often combined with atovaquone (e.g., in Malarone) or chloroquine for improved efficacy and resistance management.
Malaria Prophylaxis (Prevention):
- Adults: 200 mg once daily.
- Children: Dosage depends on body weight (consult pediatric dosing guidelines).
- Start 1–2 days before travel to endemic area, continue daily during stay, and for 7 days after leaving.
- Malaria Treatment (with Atovaquone):
- Adult dose (in combination): 250 mg atovaquone + 100 mg proguanil, four tablets once daily for 3 days.
- Proguanil 100 mg and 200 mg tablets.
- Malarone (combination):
- Adult: 250 mg atovaquone + 100 mg proguanil
- Pediatric: 62.5 mg atovaquone + 25 mg proguanil
- Take with food or a milky drink to improve absorption.
- Take at the same time each day.
- Do not skip doses—maintaining blood levels is key for efficacy.
- Class: Antifolate antimalarial (biguanide class)
- Mechanism: Proguanil is a prodrug, converted in the liver to cycloguanil, which inhibits dihydrofolate reductase in parasites, blocking DNA synthesis and replication.
- Half-life: ~12–21 hours
- Excretion: Primarily via kidneys
Common:
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Headache
- Mouth ulcers
Rare/severe:
- Hair loss (reversible)
- Allergic reactions (rash, itching, swelling)
- Hypersensitivity to proguanil or any component of the formulation
- Severe renal impairment (especially when CrCl <30 mL/min)
- Not recommended in children <5 kg (when in combination with atovaquone)
- Warfarin and other anticoagulants – may enhance effects; monitor INR.
- Metoclopramide – may reduce atovaquone absorption when combined.
- Rifampicin and tetracyclines – may decrease effectiveness of combination therapy.
- Live vaccines – effectiveness might be reduced.
Drug Status
Availability | |
Pregnancy | |
Breastfeeding | |
Schedule |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Proguanil | 100mg | Tablet | 56’s | Cosmos Ltd | Cosmos Ltd |